Advanced Enzyme Tech
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
** Enzymes and probiotics maker Advanced Enzyme Technologies' shares ADEN.NS rises as much as 17.28%, their biggest intraday percentage surge in over four years to 419 rupees, an 18-month high
** Uptick after ADEN reports a 62.2% year-on-year jump in March quarter profit
** Revenue from operations rises 21.6% to 2.03 billion rupees
** Human nutrition segment, which contributes to about 63% of the total revenue, rises 24% in the March quarter, while the animal nutrition segment is up 19% Y/Y
**Trading volume is 5,005,409 shares as of 11:10 a.m. IST, more than 18x the 30-day average volumes, data compiled LSEG shows
** ADEN up 35% in 2026 so far, exchange data shows
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
** Enzymes and probiotics maker Advanced Enzyme Technologies' shares ADEN.NS rises as much as 17.28%, their biggest intraday percentage surge in over four years to 419 rupees, an 18-month high
** Uptick after ADEN reports a 62.2% year-on-year jump in March quarter profit
** Revenue from operations rises 21.6% to 2.03 billion rupees
** Human nutrition segment, which contributes to about 63% of the total revenue, rises 24% in the March quarter, while the animal nutrition segment is up 19% Y/Y
**Trading volume is 5,005,409 shares as of 11:10 a.m. IST, more than 18x the 30-day average volumes, data compiled LSEG shows
** ADEN up 35% in 2026 so far, exchange data shows
(Reporting by Bharath Rajeswaran in Bengaluru)
(([email protected]; +91 9769003463;))
July 25 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:
ADVANCED ENZYME TECHNOLOGIES LTD - JC BIOTECH APPROVES COLLABORATION WITH RAYWATT SOLAR POWER
Source text: ID:nBSE2n5hlH
Further company coverage: ADEN.NS
(([email protected];))
July 25 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:
ADVANCED ENZYME TECHNOLOGIES LTD - JC BIOTECH APPROVES COLLABORATION WITH RAYWATT SOLAR POWER
Source text: ID:nBSE2n5hlH
Further company coverage: ADEN.NS
(([email protected];))
** Advanced Enzyme Technologies ADEN.NS falls 2.9% to 287.9 rupees
** Probiotics maker's Q4 consol net profit falls 6.5% Y/Y, hurt by an ~18% spike in expenses; rev up 6%
** More than 465,000 shares traded, ~4x the 30-day avg
** YTD, ADEN loses ~15%
(Reporting by Aleef Jahan in Bengaluru)
** Advanced Enzyme Technologies ADEN.NS falls 2.9% to 287.9 rupees
** Probiotics maker's Q4 consol net profit falls 6.5% Y/Y, hurt by an ~18% spike in expenses; rev up 6%
** More than 465,000 shares traded, ~4x the 30-day avg
** YTD, ADEN loses ~15%
(Reporting by Aleef Jahan in Bengaluru)
Dec 5 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:
UNIT TO FORM OF A NEW CORPORATION IN CALIFORNIA, US
VALUE OF ASSETS TO BE TRANSFERRED BY SEB TO STARYA LABS UPTO $500,000
Source text: ID:nBSEKTThX
Further company coverage: ADEN.NS
(([email protected];;))
Dec 5 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:
UNIT TO FORM OF A NEW CORPORATION IN CALIFORNIA, US
VALUE OF ASSETS TO BE TRANSFERRED BY SEB TO STARYA LABS UPTO $500,000
Source text: ID:nBSEKTThX
Further company coverage: ADEN.NS
(([email protected];;))
** Shares of Advanced Enzyme Technologies ADEN.NS up 3.3%
** Stock set for third straight session of gains
** Enzymes and probiotics maker's Sept-qtr consol net profit jumps 31% YoY; revenue up nearly 14%
** Trading vol is 3.3X the 30-day daily moving average
** Stock now up ~17% so far this year
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
** Shares of Advanced Enzyme Technologies ADEN.NS up 3.3%
** Stock set for third straight session of gains
** Enzymes and probiotics maker's Sept-qtr consol net profit jumps 31% YoY; revenue up nearly 14%
** Trading vol is 3.3X the 30-day daily moving average
** Stock now up ~17% so far this year
(Reporting by Manvi Pant in Bengaluru)
(([email protected]; +918447554364;))
March 31 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:
UNIT APPROVED PURCHASE OF ENTIRE BUSINESS UNDERTAKING OF SHRI GANESH INDUSTRIAL ENZYMES
ACQUISITION VIA SLUMP SALE ON A GOING CONCERN BASIS FOR UPTO 9 MILLION RUPEES
Source text for Eikon: ID:nBSE8mxSFX
Further company coverage: ADEN.NS
(([email protected];))
March 31 (Reuters) - Advanced Enzyme Technologies Ltd ADEN.NS:
UNIT APPROVED PURCHASE OF ENTIRE BUSINESS UNDERTAKING OF SHRI GANESH INDUSTRIAL ENZYMES
ACQUISITION VIA SLUMP SALE ON A GOING CONCERN BASIS FOR UPTO 9 MILLION RUPEES
Source text for Eikon: ID:nBSE8mxSFX
Further company coverage: ADEN.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Advanced Enzyme Tech do?
Advanced Enzymes Technologies Limited is the largest Indian enzyme company focusing on research, development, and manufacturing of enzymes and probiotics. Their aim is to provide side-effect free healthcare solutions, improve animal nutrition, and promote enzyme-based industrial processes.
Who are the competitors of Advanced Enzyme Tech?
Advanced Enzyme Tech major competitors are Fermenta Biotech, Concord Biotech, Biocon, Novartis India, Panacea Biotec, Unichem Laboratories, Gufic Biosciences. Market Cap of Advanced Enzyme Tech is ₹3,564 Crs. While the median market cap of its peers are ₹3,627 Crs.
Is Advanced Enzyme Tech financially stable compared to its competitors?
Advanced Enzyme Tech seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Advanced Enzyme Tech pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Advanced Enzyme Tech latest dividend payout ratio is 44.37% and 3yr average dividend payout ratio is 32.58%
How has Advanced Enzyme Tech allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments
How strong is Advanced Enzyme Tech balance sheet?
Balance sheet of Advanced Enzyme Tech is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Advanced Enzyme Tech improving?
The profit is oscillating. The profit of Advanced Enzyme Tech is ₹174 Crs for TTM, ₹131 Crs for Mar 2025 and ₹133 Crs for Mar 2024.
Is the debt of Advanced Enzyme Tech increasing or decreasing?
Yes, The net debt of Advanced Enzyme Tech is increasing. Latest net debt of Advanced Enzyme Tech is -₹95.4 Crs as of Mar-26. This is greater than Mar-25 when it was -₹193.74 Crs.
Is Advanced Enzyme Tech stock expensive?
Advanced Enzyme Tech is not expensive. Latest PE of Advanced Enzyme Tech is 21.12, while 3 year average PE is 28.93. Also latest EV/EBITDA of Advanced Enzyme Tech is 15.14 while 3yr average is 18.66.
Has the share price of Advanced Enzyme Tech grown faster than its competition?
Advanced Enzyme Tech has given lower returns compared to its competitors. Advanced Enzyme Tech has grown at ~-2.32% over the last 2yrs while peers have grown at a median rate of 11.35%
Is the promoter bullish about Advanced Enzyme Tech?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 43.26% and last quarter promoter holding is 43.04%.
Are mutual funds buying/selling Advanced Enzyme Tech?
The mutual fund holding of Advanced Enzyme Tech is decreasing. The current mutual fund holding in Advanced Enzyme Tech is 1.93% while previous quarter holding is 2.16%.